Pregnancy-associated plasma protein-A as a marker for long-term mortality in patients with peripheral atherosclerosis: Inconclusive findings from the Linz Peripheral Arterial Disease (LIPAD) study

Clinical Chemistry and Laboratory Medicine

Volumn 48, Issue 4, 2010, Pages 537-542

  Mueller, Thomas ^a   Dieplinger, Benjamin ^a   Forstner, Thomas ^b   Poelz, Werner ^b   Haltmayer, Meinhard ^a,c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b JOHANNES KEPLER UNIVERSITY LINZ   (Austria)

^c PARACELSUS MEDICAL UNIVERSITY   (Austria)

Author keywords

Metalloproteinases; Natriuretic peptides; Outcome; Peripheral artery disease; Prognosis

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; AGED; ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CLINICAL PRACTICE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEATH; ENZYME IMMUNOASSAY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; SURVIVAL RATE; TERTIARY HEALTH CARE;

ADULT; AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PREGNANCY; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; ROC CURVE;

EID: 77949836745     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2010.103     Document Type: Article

References (29)

1. Consuegra-Sanchez L, Fredericks S, Kaski JC. Pregnancy-associated plasma protein-A (PAPP-A) and cardiovascular risk. Atherosclerosis 2009;203:346-352
2. Andreotti F, Rio T, Conti E. Role of PAPP-A in atherothrombosis: messages to take home. Atherosclerosis 2009;203:353-354
3. Crea F, Andreotti F. Pregnancy associated plasma protein-A and coronary atherosclerosis: marker, friend, or foe? Eur Heart J 2005;26:2075-2076
4. Biasucci LM, Rizzello V. Pregnancy-associated plasma protein- A: do specific markers of vascular or plaque activation exist, and do we really need them? Clin Chem 2006;52:913-914
5. Harrington SC, Simari RD, Conover CA. Genetic deletion of pregnancy-associated plasma protein-A is associated with resistance to atherosclerotic lesion development in apolipoprotein E-deficient mice challenged with high-fat diet. Circ Res 2007; 100:1696-1702
6. Bayes-Genis A, Conover CA, Overgaard MT, Bailey KR, Christiansen M, Holmes DR Jr, et al. Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. N Engl J Med 2001;345:1022-1029
7. Khosravi J, Diamandi A, Krishna RG, Bodani U, Mistry J, Khaja N. Pregnancy associated plasma protein-A: ultrasensitive immunoassay and determination in coronary heart disease. Clin Biochem 2002;35:531-538
8. Qin QP, Laitinen P, Majamaa-Voltti K, Eriksson S, Kumpula EK, Pettersson K. Release patterns of pregnancy associated plasma protein A (PAPP-A) in patients with acute coronary syndromes. Scand Cardiovasc J 2002;36:358-361
9. Lund J, Qin QP, Ilva T, Pettersson K, Voipio-Pulkki LM, Porela P, et al. Circulating pregnancy-associated plasma protein a predicts outcome in patients with acute coronary syndrome but no troponin I elevation. Circulation 2003;108:1924-1926
10. Heeschen C, Dimmeler S, Hamm CW, Fichtlscherer S, Simoons ML, Zeiher AM, CAPTURE Study Investigators. Pregnancyassociated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis. J Am Coll Cardiol 2005;45:229-237
11. Cosin-Sales J, Kaski JC, Christiansen M, Kaminski P, Oxvig C, Overgaard MT, et al. Relationship among pregnancy associated plasma protein-A levels, clinical characteristics, and coronary artery disease extent in patients with chronic stable angina pectoris. Eur Heart J 2005;26:2093-2098
12. Elesber AA, Conover CA, Denktas AE, Lennon RJ, Holmes DR Jr, Overgaard MT, et al. Prognostic value of circulating pregnancy-associated plasma protein levels in patients with chronic stable angina. Eur Heart J 2006;27:1678-1684
13. Consuegra-Sanchez L, Petrovic I, Cosin-Sales J, Holt DW, Christiansen M, Kaski JC. Prognostic value of circulating pregnancy- associated plasma protein-A (PAPP-A) and proform of eosinophil major basic protein (pro-MBP) levels in patients with chronic stable angina pectoris. Clin Chim Acta 2008;391: 18-23.
14. Beaudeux JL, Burc L, Imbert-Bismut F, Giral P, Bernard M, Bruckert E, et al. Serum plasma pregnancy-associated protein A: a potential marker of echogenic carotid atherosclerotic plaques in asymptomatic hyperlipidemic subjects at high cardiovascular risk. Arterioscler Thromb Vasc Biol 2003;23:e7-10.
15. Aso Y, Okumura K, Wakabayashi S, Takebayashi K, Taki S, Inukai T. Elevated pregnancy-associated plasma protein-A in sera from type 2 diabetic patients with hypercholesterolemia: associations with carotid atherosclerosis and toe-brachial index. J Clin Endocrinol Metab 2004;89:5713-5717
16. Mueller T, Dieplinger B, Poelz W, Haltmayer M. Increased pregnancy-associated plasma protein-A as a marker for peripheral atherosclerosis: results from the Linz peripheral arterial disease study. Clin Chem 2006;52:1096-1103
17. Mueller T, Marschon R, Dieplinger B, Haidinger D, Gegenhuber A, Poelz W, et al. Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz peripheral arterial disease (LIPAD) study. J Vasc Surg 2005;41:808-815
18. Mueller T, Dieplinger B, Poelz W, Endler G, Wagner OF, Haltmayer M. Amino-terminal pro-B-type natriuretic peptide as predictor of mortality in patients with symptomatic peripheral arterial disease: 5-year follow-up data from the Linz peripheral arterial disease study. Clin Chem 2009;55:68-77.
19. Dieplinger B, Haltmayer M, Poelz W, Mueller T. Value of adiponectin as predictor of 5-year all-cause mortality in patients with symptomatic peripheral arterial disease: results from the Linz peripheral arterial disease (LIPAD) study. Clin Chim Acta 2009;408:87-91.
20. Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 1997; 26:517-538
21. Terkelsen CJ, Oxvig C, Nørgaard BL, Glerup S, Poulsen TS, Lassen JF, et al. Temporal course of pregnancy-associated plasma protein-A in angioplasty-treated ST-elevation myocardial infarction patients and potential significance of concomitant heparin administration. Am J Cardiol 2009;103:29-35.
22. Tertti R, Wittfooth S, Porela P, Airaksinen KE, Metsärinne K, Pettersson K. Intravenous administration of low molecular weight and unfractionated heparin elicits a rapid increase in serum pregnancy-associated plasma protein A. Clin Chem 2009;55:1214-1217
23. Miedema MD, Conover CA, MacDonald H, Harrington SC, Oberg D, Wilson D, et al. Pregnancy-associated plasma protein- A elevation in patients with acute coronary syndrome and subsequent atorvastatin therapy. Am J Cardiol 2008;101:35-39
24. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983;148:839-843
25. Belch JJ, Topol EJ, Agnelli G, Bertrand M, Califf RM, Clement DL, et al. Prevention of Atherothrombotic Disease Network. Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med 2003;163:884-892
26. Qin QP, Kokkala S, Lund J, Tamm N, Voipio-Pulkki LM, Pettersson K. Molecular distinction of circulating pregnancy-associated plasma protein A in myocardial infarction and pregnancy. Clin Chem 2005;51:75-83.
27. Qin QP, Kokkala S, Lund J, Tamm N, Qin X, Lepäntalo M, et al. Immunoassays developed for pregnancy-associated plasma protein-A (PAPP-A) in pregnancy may not recognize PAPP-A in acute coronary syndromes. Clin Chem 2006;52:398-404.
28. Wittfooth S, Qin QP, Lund J, Tierala I, Pulkki K, Takalo H, et al. Immunofluorometric point-of-care assays for the detection of acute coronary syndrome-related noncomplexed pregnancyassociated plasma protein A. Clin Chem 2006;52:1794-1801
29. Wittfooth S, Qin QP, Pettersson K. Performance of immunofluorometric point-of-care assays for free pregnancy-associated plasma protein A detection in whole blood samples. Clin Chem Lab Med 2008;46:18-20.